Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemotherapy and radiation therapy].

T Matsuo1, M Tomonaga

  • 1Blood Transfusion Service, Nagasaki University Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Morphological diagnoses of the Japan adult leukemia study group acute myeloid leukemia protocols: central review.

International journal of hematology·2001
Same author

Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells.

Leukemia·2001
Same author

Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki.

Blood·2001
Same author

Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.

Cancer research·2001
Same author

Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells.

Biochemical and biophysical research communications·2001
Same author

ATRA, NF-kappaB and ATL.

Leukemia research·2001

For chronic phase CML, hydroxyurea and homoharringtonine offer better options than older chemotherapy. However, advanced CML phases still lack effective treatments despite ongoing clinical trials.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Stem cell transplantation and interferon therapy are primary treatments for chronic myeloid leukemia (CML).
  • Chemotherapy options are limited, especially when first-line treatments fail or are unavailable.
  • Hydroxyurea shows better efficacy and fewer side effects compared to busulfan.

Purpose of the Study:

  • To review therapeutic options for chronic phase CML.
  • To evaluate the effectiveness of hydroxyurea and homoharringtonine.
  • To assess treatment outcomes for accelerated and blastic phases of CML.

Main Methods:

  • Literature review of existing studies on CML treatments.
  • Comparison of efficacy and side effect profiles of different chemotherapeutic agents.

Related Experiment Videos

  • Analysis of clinical trial data for advanced CML phases.

    • Main Results:

    • Hydroxyurea is more effective and better tolerated than busulfan for CML.
    • Homoharringtonine achieved cytogenetic response in one-third of interferon-resistant patients.
    • Homoharringtonine showed improved response rates when combined with cytarabine and interferon alfa.
    • No significant improvements in clinical outcomes have been observed for accelerated or blastic phases of CML.

    Conclusions:

    • Hydroxyurea and homoharringtonine represent valuable therapeutic advancements for chronic phase CML.
    • Current treatments offer limited benefit for advanced CML phases, necessitating further research and clinical trials.